Stock listing
VTGN Stock Price, News, Filings & Events — Vistagen Therapeutics, Inc.
Selected listing: VTGN · BMV · MXN · MX
This page tracks Vistagen Therapeutics, Inc.'s VTGN:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VTGN:BMV. VTGN:BMV is the stock-level entry point for investors researching Vistagen Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vistagen Therapeutics, Inc. is a public company traded under the ticker VTGN in the American market. The company has a market capitalization of approximately $9.4 million. Vistagen focuses on developing therapies for central nervous system disorders.

- Ticker
- VTGN:BMV
- Asset type
- Stock
- Market cap
- $9.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
Vistagen Therapeutics, Inc. VTGN:BMV stock context
This page tracks Vistagen Therapeutics, Inc.'s VTGN:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VTGN:BMV. VTGN:BMV is the stock-level entry point for investors researching Vistagen Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vistagen Therapeutics, Inc. is a public company traded under the ticker VTGN in the American market. The company has a market capitalization of approximately $9.4 million. Vistagen focuses on developing therapies for central nervous system disorders.
Research Vistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for VTGN:BMV.
Vistagen Therapeutics, Inc. company profile
View the public company page for Vistagen Therapeutics, Inc. on 6ix.
Vistagen Therapeutics, Inc. news
Read company news and market updates connected to Vistagen Therapeutics, Inc..
Vistagen Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Vistagen Therapeutics, Inc..
Alternate listings
VTGN:NASDAQ
US · USD
Alternate listing for Vistagen Therapeutics, Inc.; the primary context on this page is VTGN:BMV.
VTGN:BOATS
US · USD
Alternate listing for Vistagen Therapeutics, Inc.; the primary context on this page is VTGN:BMV.
VTGN:BIVA
MX · MXN
Alternate listing for Vistagen Therapeutics, Inc.; the primary context on this page is VTGN:BMV.